Latest Capital Raising And Placements News

Tryptamine Therapeutics has raised $6.1 million to fast-track clinical development of its IV-infused psilocin drug TRP-8803, targeting binge eating disorder and other neuropsychiatric conditions.

Volt Resources has raised $2.23 million through a share placement to fund the feasibility study and development of its high purity graphite refinery in Alabama, alongside advancing a pilot plant for ultra-high purity graphite.

PARKD Limited has raised $1 million to fund its East Coast expansion, secured a new prefabrication facility in NSW, and landed its first pilot project with McNab Group, marking a pivotal step in its national rollout.

Olympio Metals has reported significant high-grade gold intersections from its Bousquet Gold Project in Quebec, alongside a $1.6 million capital raise to accelerate exploration and drilling activities.

EMVision Medical Devices has successfully closed an oversubscribed Share Purchase Plan, raising $2 million and bringing total recent capital to $14 million. This funding positions the company to advance pivotal clinical trials and regulatory milestones for its innovative neurodiagnostic devices.

Tasman Resources has progressed its exploration efforts at Lake Torrens and Parkinson Dam projects, backed by a recent $850,000 capital raise and strategic board changes.

Jindalee Lithium reported a challenging quarter with over A$2 million in cash outflows but bolstered its funding position with a recent $8 million share placement, extending its operational runway.

Aspermont Limited reports a milestone $11.2 million annual recurring revenue with its new Mining-IQ platform gaining traction through a landmark Rio Tinto contract. The company also strengthens its balance sheet with a $2.8 million capital raise, setting the stage for accelerated growth.

Silver Mines Limited progresses regulatory approvals for its flagship Bowdens Silver Project in NSW, secures $34 million through capital raising, and acquires promising US exploration assets, setting the stage for growth.

Enterprise Metals Limited reported promising drilling results and secured significant funding to advance multiple Western Australian projects in gold, copper, and rare earths exploration.

Alicanto Minerals has completed a summer exploration program in Sweden, revealing promising copper, silver, and gold targets across its Falun and Sala projects. The company also secured A$3 million in fresh capital to fund ongoing exploration and strategic acquisitions.

Biotron Limited has advanced its Hepatitis B antiviral program while preparing to acquire Sedarex Limited, backed by a $2.5 million capital raise. The move signals a strategic expansion into safer anaesthetics alongside ongoing R&D progress.